FDA Approves Opioids Designed to Eliminate Addiction Risk
U.S. federal officials have approved a new pain pill aimed at preventing addiction and overdose risks linked to opioids like Vicodin and OxyContin. Journavx (suzetrigine) 50 milligram oral tablets, is the first drug to be approved in this new class of pain management medicines.
Vertex Pharmaceuticals ( VRTX 5.31%) just snagged its second U.S. Food and Drug Administration (FDA) approval in only 41 days. On Dec. 20, 2024, the FDA gave a thumbs-up to Alyftrek in treating cystic ...
The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback